Joshua Foukas sold $187k of USNA
CHIEF LEGAL OFFICER at USANA HEALTH SCIENCES INC. 5,732 shares at an average of $32.54, traded Mar 12, 2025, filed Mar 13, 2025.
Score components
- +15RoleOfficer
- +12Trade size$187k at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000896264-25-000096, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 12, 2025 | SOpen-market sale Common Stock | -5,732 | $32.54 | $187k | 0 | Mar 13, 2025 |
Related signals
Other insiders at USANA HEALTH SCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | USANA HEALTH SCIENCES INC | John Turman Fleming director | $17k 500 shares | -11% | |
| 50Moderate | USANA HEALTH SCIENCES INC | Gilbert A Fuller director | $21k 674 shares | -100% | |
| 56Moderate | USANA HEALTH SCIENCES INC | Jim Brown CEO & PRESIDENT | $147k 5,000 shares | -24% | |
| 25Weak | USNAsell USANA HEALTH SCIENCES INC | Gilbert A Fuller director | $25k 675 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.